Project Grant 2537342
Award Date 7/1/26
Completion Date 6/30/27
Dollars Obligated $305K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Woodland Hills, CA 91367, USA
Similar Awards
- Federal Grant Award Summary Integrated Medical Sensors Inc., a minority-owned small disadvantaged business located in Irvine, California, received a $275,275 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) effective September 17, 2025, with completion targeted for August 31, 2026. The award supports the development and optimization of...
- The National Science Foundation (NSF) awarded a $275,000 Small Business Innovation Research (SBIR) Phase I project grant to Agil Therapeutics Inc. under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084). This two-year project aims to develop a novel cryoablation system for minimally invasive treatment of type 2 diabetes. The system is designed to deliver a highly controlled and targeted cryogenic agent to the duodenum, with the goal of remodeling the duodenal tissue to...
- Federal Cooperative Agreement Summary Superior Nano LLC received a Phase II Small Business Innovation Research (SBIR) Cooperative Agreement valued at $1,247,672 from the National Science Foundation (NSF) Technology, Innovation, and Partnerships program (CFDA 47.084), effective July 15, 2025, with a completion date of June 30, 2027. The award funds development of Dense Nanolipid Fluids (DNLFs) technology to create the first oral insulin delivery system for diabetes patients. Building on a...
- Federal Grant Award Summary In Vivo Microsystems Technologies, LLC received a $2.04 million Phase 2 Small Business Innovation Research (SBIR) Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). Awarded on September 19, 2025, with completion targeted for August 31, 2027, this grant supports a multi-center clinical study to advance a novel near-infrared (NIR)...
- Federal Grant Award Summary: Raylife Inc. – Non-Invasive Glucose Monitoring Technology Raylife Inc. received a $304,898 Small Business Innovation Research (SBIR) Phase I award from the National Science Foundation's Directorate for Technology, Innovation, and Partnerships (CFDA 47.084) for the period July 1, 2026 through June 30, 2027. The project focuses on developing a needle-free, wearable optoelectronic device capable of non-invasive, continuous blood glucose monitoring. The technology...
- This Project Grant award from the National Science Foundation's (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program will fund the development of an advanced wound care product to treat diabetic foot ulcers. The $305,000 award to Therapeutic Bandage Products, Inc. will support the creation of a patented microneedle bandage that delivers three therapeutic agents to disinfect the wound, prevent bacterial biofilm formation, and attract white blood cells to aid healing. This...
- Federal Project Grant Award Summary Integrated Medical Sensors Inc. received a $569,998 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 1, 2025 through July 31, 2026. The award funds the development and validation of optimized data processing algorithms for real-time glucose monitoring on the company's proprietary multi-sensor...
- Federal Grant Award Summary Persista Bio Inc. received a $3.28 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded on September 8, 2025, with a completion date of August 31, 2027. The grant supports advanced preclinical development of the O2LINE System, a safe, anti-fibrotic, oxygenated cell encapsulation device designed for Type 1 Diabetes...
- This SBIR Phase I project, awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program, is focused on the development of a novel mammalian cell-based nano-biological coating for implantable medical devices. The goal is to address the critical health and economic burden associated with implant-related infections by reducing or eliminating them through the use of this biocompatible and antimicrobial nano-biological coating. The $305,000...
- Federal Project Grant Summary The National Institute of Diabetes and Digestive and Kidney Diseases awarded Microvascular Tissues, Inc. a $700,000 Project Grant on September 17, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to evaluate the efficacy of its Microvascular Tissue Graft (MVASC) treatment in rat models of diabetic peripheral neuropathy (DPN). MVASC is a novel human structural allograft consisting of lyophilized and terminally...